Specialty Pharma Journal Specialty, Precision & Technology
By Kathleen P. Wolff, MBA Specialty Pharma Journal Forging a pathway of innovation is typically easier with friends and allies. But these days, in the world of biosimilars, where stakeholders are still sizing each other up, allies are scarce. At the Biosimilars 20/20 conference in Philadelphia, the consensus among key opinion …
Tag Archives: Avalere Health
June, 2015
-
10 June
Ten Breakthrough Drugs will Cost the US Nearly $50 Billion Over Ten Years
There has been heavy debate over the high cost of prescription drugs, and an analysis by Avalere Health estimates that the federal government will spend nearly $50 billion over the next decade on ten breakthrough drugs. The US Food and Drug Administration’s (FDA) new Breakthrough Therapy program is designed to …